A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial Testing Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative To Placebo Plus Abiraterone Plus Prednisone/Prednisolone In Adult Male Patients With Asymptomatic Or Mildly Symptomatic, Previously Untreated, Metastatic Castrate-Resistant Prostate Cancer

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/17/MH/107
NMA SSA Reference Number: SSA/17/MonH/231
Monash Health Ref: RES-17-0000-298X
Effective start/end date6/05/195/05/24


  • clinical trial
  • treatment efficacy
  • prostate cancer